182 related articles for article (PubMed ID: 29258398)
21. Bimodal plasma metabolomics strategy identifies novel inflammatory metabolites in inflammatory bowel diseases.
Yau YY; Leong RW; Shin S; Bustamante S; Pickford R; Hejazi L; Campbell B; Wasinger VC
Discov Med; 2014 Sep; 18(98):113-24. PubMed ID: 25227752
[TBL] [Abstract][Full Text] [Related]
22. Exploration of serum metabolomic profiles and outcomes in women with metastatic breast cancer: a pilot study.
Tenori L; Oakman C; Claudino WM; Bernini P; Cappadona S; Nepi S; Biganzoli L; Arbushites MC; Luchinat C; Bertini I; Di Leo A
Mol Oncol; 2012 Aug; 6(4):437-44. PubMed ID: 22687601
[TBL] [Abstract][Full Text] [Related]
23. Breast cancer detection using targeted plasma metabolomics.
Jasbi P; Wang D; Cheng SL; Fei Q; Cui JY; Liu L; Wei Y; Raftery D; Gu H
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jan; 1105():26-37. PubMed ID: 30562627
[TBL] [Abstract][Full Text] [Related]
24. Using post-column infused internal standard assisted quantitative metabolomics for establishing prediction models for breast cancer detection.
Huang M; Li HY; Liao HW; Lin CH; Wang CY; Kuo WH; Kuo CH
Rapid Commun Mass Spectrom; 2020 Apr; 34 Suppl 1():e8581. PubMed ID: 31693758
[TBL] [Abstract][Full Text] [Related]
25. Systematic review of genetic polymorphisms associated with psychoneurological symptoms in breast cancer survivors.
Yang GS; Kumar S; Dorsey SG; Starkweather AR; Kelly DL; Lyon DE
Support Care Cancer; 2019 Feb; 27(2):351-371. PubMed ID: 30343412
[TBL] [Abstract][Full Text] [Related]
26. Potential epigenetic mechanism(s) associated with the persistence of psychoneurological symptoms in women receiving chemotherapy for breast cancer: a hypothesis.
Lyon D; Elmore L; Aboalela N; Merrill-Schools J; McCain N; Starkweather A; Elswick RK; Jackson-Cook C
Biol Res Nurs; 2014 Apr; 16(2):160-74. PubMed ID: 23585573
[TBL] [Abstract][Full Text] [Related]
27. The metabolomics approach revealed a distinctive metabolomics pattern associated with hyperthyroidism treatment.
Jaber MA; Benabdelkamel H; Dahabiyeh LA; Masood A; AlMalki RH; Musambil M; Alfadda AA; Abdel Rahman AM
Front Endocrinol (Lausanne); 2022; 13():1050201. PubMed ID: 36440210
[TBL] [Abstract][Full Text] [Related]
28. A joint analysis of metabolomics and genetics of breast cancer.
Tang X; Lin CC; Spasojevic I; Iversen ES; Chi JT; Marks JR
Breast Cancer Res; 2014 Aug; 16(4):415. PubMed ID: 25091696
[TBL] [Abstract][Full Text] [Related]
29. A metabolome-wide case-control study of african american breast cancer patients.
Luo J; Kibriya MG; Chen H; Kim K; Ahsan H; Olopade OI; Olopade CS; Aschebrook-Kilfoy B; Huo D
BMC Cancer; 2023 Feb; 23(1):183. PubMed ID: 36823587
[TBL] [Abstract][Full Text] [Related]
30. Early Breast Cancer Detection Using Untargeted and Targeted Metabolomics.
Wei Y; Jasbi P; Shi X; Turner C; Hrovat J; Liu L; Rabena Y; Porter P; Gu H
J Proteome Res; 2021 Jun; 20(6):3124-3133. PubMed ID: 34033488
[TBL] [Abstract][Full Text] [Related]
31. A plasma metabolomic signature discloses human breast cancer.
Jové M; Collado R; Quiles JL; Ramírez-Tortosa MC; Sol J; Ruiz-Sanjuan M; Fernandez M; de la Torre Cabrera C; Ramírez-Tortosa C; Granados-Principal S; Sánchez-Rovira P; Pamplona R
Oncotarget; 2017 Mar; 8(12):19522-19533. PubMed ID: 28076849
[TBL] [Abstract][Full Text] [Related]
32. Patterns of circadian activity rhythms and their relationships with fatigue and anxiety/depression in women treated with breast cancer adjuvant chemotherapy.
Berger AM; Wielgus K; Hertzog M; Fischer P; Farr L
Support Care Cancer; 2010 Jan; 18(1):105-14. PubMed ID: 19381692
[TBL] [Abstract][Full Text] [Related]
33. Metabolomic profiles in breast cancer:a pilot case-control study in the breast cancer family registry.
Dougan MM; Li Y; Chu LW; Haile RW; Whittemore AS; Han SS; Moore SC; Sampson JN; Andrulis IL; John EM; Hsing AW
BMC Cancer; 2018 May; 18(1):532. PubMed ID: 29728083
[TBL] [Abstract][Full Text] [Related]
34. A metabolic profile of routine needle biopsies identified tumor type specific metabolic signatures for breast cancer stratification: a pilot study.
Harada-Shoji N; Soga T; Tada H; Miyashita M; Harada M; Watanabe G; Hamanaka Y; Sato A; Suzuki T; Suzuki A; Ishida T
Metabolomics; 2019 Nov; 15(11):147. PubMed ID: 31686242
[TBL] [Abstract][Full Text] [Related]
35. Relationship of systemic cytokine concentrations to cognitive function over two years in women with early stage breast cancer.
Lyon DE; Cohen R; Chen H; Kelly DL; McCain NL; Starkweather A; Ahn H; Sturgill J; Jackson-Cook CK
J Neuroimmunol; 2016 Dec; 301():74-82. PubMed ID: 27890459
[TBL] [Abstract][Full Text] [Related]
36. Exploring Associations Between Metabolites and Symptoms of Fatigue, Depression and Pain in Women With Fibromyalgia.
Menzies V; Starkweather A; Yao Y; Kelly DL; Garrett TJ; Yang G; Booker S; Swift-Scanlan T; Mahmud I; Lyon DE
Biol Res Nurs; 2021 Jan; 23(1):119-126. PubMed ID: 32677448
[TBL] [Abstract][Full Text] [Related]
37. Serum metabolomic profiles evaluated after surgery may identify patients with oestrogen receptor negative early breast cancer at increased risk of disease recurrence. Results from a retrospective study.
Tenori L; Oakman C; Morris PG; Gralka E; Turner N; Cappadona S; Fornier M; Hudis C; Norton L; Luchinat C; Di Leo A
Mol Oncol; 2015 Jan; 9(1):128-39. PubMed ID: 25151299
[TBL] [Abstract][Full Text] [Related]
38. Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism?
Bower JE; Ganz PA; Irwin MR; Kwan L; Breen EC; Cole SW
J Clin Oncol; 2011 Sep; 29(26):3517-22. PubMed ID: 21825266
[TBL] [Abstract][Full Text] [Related]
39. The effect of a 12-week home-based walking program on reducing fatigue in women with breast cancer undergoing chemotherapy: A randomized controlled study.
Huang HP; Wen FH; Yang TY; Lin YC; Tsai JC; Shun SC; Jane SW; Chen ML
Int J Nurs Stud; 2019 Nov; 99():103376. PubMed ID: 31442785
[TBL] [Abstract][Full Text] [Related]
40. A Pilot Study Using a Multistaged Integrated Analysis of Gene Expression and Methylation to Evaluate Mechanisms for Evening Fatigue in Women Who Received Chemotherapy for Breast Cancer.
Flowers E; Flentje A; Levine J; Olshen A; Hammer M; Paul S; Conley Y; Miaskowski C; Kober KM
Biol Res Nurs; 2019 Mar; 21(2):142-156. PubMed ID: 30701989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
